Newsroom
Category
December 15, 2016
Tim Huang, Ph.D., was named interim director, and Randy Otto, M.D., was appointed as director for clinical affairs and physician-in-chief at the UT Health San Antonio MD Anderson Cancer Center
December 15, 2016
Greg Aune, an assistant professor of pediatrics at the University of Texas Health Science Center at San Antonio, shares how he coped with being diagnosed with Hodgkin’s lymphoma at the age of 16.
December 5, 2016
More than 7,000 oncologists, cancer researchers and patient advocates will converge on San Antonio Dec. 6-10 for the 39th San Antonio Breast Cancer Symposium (SABCS) in the Henry B. Gonzalez Convention Center. Among them will be researchers and oncologists from the Cancer Therapy & Research Center of the UT Health Science Center San Antonio, which founded the conference in 1978.
December 5, 2016
More than 7,000 oncologists, cancer researchers and patient advocates will converge on San Antonio Dec. 6-10 for the 39th San Antonio Breast Cancer Symposium (SABCS) in the Henry B. Gonzalez Convention Center.
December 1, 2016
Adding everolimus to fulvestrant in postmenopausal women with hormone receptor (HR)-positive/HER2-negative, aromatase inhibitor (AI)-resistant metastatic breast cancer improved progression-free survival (PFS) to 10.4 months, compared with 5.1 months for fulvestrant alone, in the randomized, double-blind, Phase II PrECOG 0102 trial. Read the full story at Clinical Oncology News
December 1, 2016
Adding the PARP inhibitor veliparib to carboplatin and paclitaxel chemotherapy significantly increased response rates among women with BRCA1 or BRCA2 mutations and locally recurrent or metastatic breast cancer, according to a randomized phase II trial. Read the full story at Cancer Network